Cannabis and Oncology: Adjunctive Treatments

Explores the role of cannabinoids in cancer care, highlighting palliative and adjunctive therapies for symptom management. Nausea, pain, appetite loss, and mood disturbances are key focus areas. Preclinical and clinical evidence of cannabinoid interactions with chemotherapy are presented. Mechanistic insights into tumor modulation and immune enhancement are discussed. Formulation strategies for maximizing efficacy and minimizing adverse effects are highlighted. Future directions for oncology-integrated cannabinoid therapies are explored.

    Related Conference of Cannabis and Oncology: Adjunctive Treatments

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Cannabis and Oncology: Adjunctive Treatments Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in